nodes	percent_of_prediction	percent_of_DWPC	metapath
Nortriptyline—HTR1A—Parkinson's disease	0.191	0.255	CbGaD
Nortriptyline—DRD2—Parkinson's disease	0.162	0.216	CbGaD
Nortriptyline—CYP2E1—Parkinson's disease	0.156	0.208	CbGaD
Nortriptyline—HTR2A—Parkinson's disease	0.125	0.167	CbGaD
Nortriptyline—CYP2D6—Parkinson's disease	0.115	0.153	CbGaD
Nortriptyline—SLC6A2—locus ceruleus—Parkinson's disease	0.00417	0.047	CbGeAlD
Nortriptyline—HTR2A—enteric nervous system—Parkinson's disease	0.00379	0.0428	CbGeAlD
Nortriptyline—SLC6A2—sympathetic nervous system—Parkinson's disease	0.00329	0.0372	CbGeAlD
Nortriptyline—HTR2A—myenteric nerve plexus—Parkinson's disease	0.00287	0.0324	CbGeAlD
Nortriptyline—HTR2A—locus ceruleus—Parkinson's disease	0.0025	0.0283	CbGeAlD
Nortriptyline—HTR2C—telencephalic ventricle—Parkinson's disease	0.00237	0.0267	CbGeAlD
Nortriptyline—SLC6A2—autonomic nervous system—Parkinson's disease	0.00221	0.025	CbGeAlD
Nortriptyline—HTR2A—cerebellar cortex—Parkinson's disease	0.00204	0.023	CbGeAlD
Nortriptyline—HTR1A—telencephalic ventricle—Parkinson's disease	0.00199	0.0225	CbGeAlD
Nortriptyline—HTR2A—sympathetic nervous system—Parkinson's disease	0.00198	0.0223	CbGeAlD
Nortriptyline—DRD2—telencephalic ventricle—Parkinson's disease	0.0018	0.0203	CbGeAlD
Nortriptyline—HTR2A—pons—Parkinson's disease	0.00144	0.0163	CbGeAlD
Nortriptyline—HTR2A—autonomic nervous system—Parkinson's disease	0.00133	0.015	CbGeAlD
Nortriptyline—SLC6A2—nerve—Parkinson's disease	0.00125	0.0141	CbGeAlD
Nortriptyline—HTR2A—telencephalic ventricle—Parkinson's disease	0.00119	0.0134	CbGeAlD
Nortriptyline—DRD2—nerve—Parkinson's disease	0.00113	0.0128	CbGeAlD
Nortriptyline—HTR6—forebrain—Parkinson's disease	0.00107	0.0121	CbGeAlD
Nortriptyline—SLC6A4—hindbrain—Parkinson's disease	0.00106	0.012	CbGeAlD
Nortriptyline—HTR2A—peripheral nervous system—Parkinson's disease	0.00096	0.0108	CbGeAlD
Nortriptyline—HTR1A—hindbrain—Parkinson's disease	0.000941	0.0106	CbGeAlD
Nortriptyline—ADRA1A—hindbrain—Parkinson's disease	0.000867	0.00979	CbGeAlD
Nortriptyline—DRD2—hindbrain—Parkinson's disease	0.00085	0.00959	CbGeAlD
Nortriptyline—ADRA1D—forebrain—Parkinson's disease	0.000835	0.00942	CbGeAlD
Nortriptyline—HTR2A—nerve—Parkinson's disease	0.000748	0.00845	CbGeAlD
Nortriptyline—CHRM4—head—Parkinson's disease	0.000684	0.00772	CbGeAlD
Nortriptyline—CHRM4—nervous system—Parkinson's disease	0.000649	0.00732	CbGeAlD
Nortriptyline—CHRM2—forebrain—Parkinson's disease	0.000641	0.00724	CbGeAlD
Nortriptyline—HTR2C—brainstem—Parkinson's disease	0.000641	0.00723	CbGeAlD
Nortriptyline—CHRM4—central nervous system—Parkinson's disease	0.000625	0.00705	CbGeAlD
Nortriptyline—HTR2C—forebrain—Parkinson's disease	0.000618	0.00698	CbGeAlD
Nortriptyline—HTR6—head—Parkinson's disease	0.000613	0.00691	CbGeAlD
Nortriptyline—SLC6A4—brainstem—Parkinson's disease	0.000607	0.00685	CbGeAlD
Nortriptyline—SLC6A4—forebrain—Parkinson's disease	0.000586	0.00661	CbGeAlD
Nortriptyline—CHRM1—forebrain—Parkinson's disease	0.000584	0.00659	CbGeAlD
Nortriptyline—HTR6—nervous system—Parkinson's disease	0.000581	0.00655	CbGeAlD
Nortriptyline—HTR2A—hindbrain—Parkinson's disease	0.000561	0.00633	CbGeAlD
Nortriptyline—HTR6—central nervous system—Parkinson's disease	0.000559	0.00631	CbGeAlD
Nortriptyline—CHRM2—cardiovascular system—Parkinson's disease	0.000542	0.00612	CbGeAlD
Nortriptyline—HTR1A—brainstem—Parkinson's disease	0.000539	0.00608	CbGeAlD
Nortriptyline—CHRM5—head—Parkinson's disease	0.000535	0.00604	CbGeAlD
Nortriptyline—SLC6A2—brainstem—Parkinson's disease	0.000535	0.00603	CbGeAlD
Nortriptyline—CHRM3—forebrain—Parkinson's disease	0.000522	0.0059	CbGeAlD
Nortriptyline—HTR1A—forebrain—Parkinson's disease	0.00052	0.00587	CbGeAlD
Nortriptyline—SLC6A2—forebrain—Parkinson's disease	0.000516	0.00582	CbGeAlD
Nortriptyline—CYP2D6—hindbrain—Parkinson's disease	0.000511	0.00576	CbGeAlD
Nortriptyline—CHRM5—nervous system—Parkinson's disease	0.000507	0.00572	CbGeAlD
Nortriptyline—ADRA1A—brainstem—Parkinson's disease	0.000497	0.00561	CbGeAlD
Nortriptyline—CHRM4—brain—Parkinson's disease	0.000496	0.0056	CbGeAlD
Nortriptyline—CHRM1—cardiovascular system—Parkinson's disease	0.000494	0.00557	CbGeAlD
Nortriptyline—ADRA1B—head—Parkinson's disease	0.000489	0.00552	CbGeAlD
Nortriptyline—CHRM5—central nervous system—Parkinson's disease	0.000488	0.00551	CbGeAlD
Nortriptyline—DRD2—brainstem—Parkinson's disease	0.000487	0.0055	CbGeAlD
Nortriptyline—ADRA1A—forebrain—Parkinson's disease	0.00048	0.00541	CbGeAlD
Nortriptyline—ADRA1D—head—Parkinson's disease	0.000478	0.0054	CbGeAlD
Nortriptyline—DRD2—forebrain—Parkinson's disease	0.00047	0.00531	CbGeAlD
Nortriptyline—ADRA1B—nervous system—Parkinson's disease	0.000463	0.00523	CbGeAlD
Nortriptyline—ADRA1D—nervous system—Parkinson's disease	0.000453	0.00512	CbGeAlD
Nortriptyline—HTR2C—medulla oblongata—Parkinson's disease	0.000447	0.00504	CbGeAlD
Nortriptyline—ADRA1B—central nervous system—Parkinson's disease	0.000446	0.00504	CbGeAlD
Nortriptyline—HTR6—brain—Parkinson's disease	0.000444	0.00501	CbGeAlD
Nortriptyline—ORM1—spinal cord—Parkinson's disease	0.000443	0.005	CbGeAlD
Nortriptyline—HTR1A—cardiovascular system—Parkinson's disease	0.00044	0.00497	CbGeAlD
Nortriptyline—ADRA1D—central nervous system—Parkinson's disease	0.000436	0.00493	CbGeAlD
Nortriptyline—HTR2C—midbrain—Parkinson's disease	0.000408	0.00461	CbGeAlD
Nortriptyline—ADRA1A—cardiovascular system—Parkinson's disease	0.000406	0.00458	CbGeAlD
Nortriptyline—HTR2C—spinal cord—Parkinson's disease	0.000398	0.00449	CbGeAlD
Nortriptyline—CHRM5—brain—Parkinson's disease	0.000388	0.00438	CbGeAlD
Nortriptyline—SLC6A4—midbrain—Parkinson's disease	0.000387	0.00437	CbGeAlD
Nortriptyline—SLC6A4—spinal cord—Parkinson's disease	0.000378	0.00426	CbGeAlD
Nortriptyline—ORM1—nervous system—Parkinson's disease	0.000373	0.00421	CbGeAlD
Nortriptyline—SLC6A2—medulla oblongata—Parkinson's disease	0.000373	0.00421	CbGeAlD
Nortriptyline—HRH1—forebrain—Parkinson's disease	0.000371	0.00419	CbGeAlD
Nortriptyline—CHRM2—head—Parkinson's disease	0.000367	0.00414	CbGeAlD
Nortriptyline—ORM1—central nervous system—Parkinson's disease	0.000359	0.00406	CbGeAlD
Nortriptyline—ADRA1B—brain—Parkinson's disease	0.000354	0.004	CbGeAlD
Nortriptyline—HTR2C—head—Parkinson's disease	0.000354	0.00399	CbGeAlD
Nortriptyline—HTR2A—embryo—Parkinson's disease	0.000351	0.00396	CbGeAlD
Nortriptyline—CHRM2—nervous system—Parkinson's disease	0.000348	0.00393	CbGeAlD
Nortriptyline—ADRA1D—brain—Parkinson's disease	0.000347	0.00391	CbGeAlD
Nortriptyline—PTGS1—forebrain—Parkinson's disease	0.000344	0.00388	CbGeAlD
Nortriptyline—HTR1A—midbrain—Parkinson's disease	0.000344	0.00388	CbGeAlD
Nortriptyline—HTR2C—nervous system—Parkinson's disease	0.000336	0.00379	CbGeAlD
Nortriptyline—SLC6A4—head—Parkinson's disease	0.000336	0.00379	CbGeAlD
Nortriptyline—HTR1A—spinal cord—Parkinson's disease	0.000335	0.00378	CbGeAlD
Nortriptyline—CHRM2—central nervous system—Parkinson's disease	0.000335	0.00378	CbGeAlD
Nortriptyline—CHRM1—head—Parkinson's disease	0.000334	0.00377	CbGeAlD
Nortriptyline—HTR2C—central nervous system—Parkinson's disease	0.000323	0.00365	CbGeAlD
Nortriptyline—HTR2A—brainstem—Parkinson's disease	0.000321	0.00363	CbGeAlD
Nortriptyline—CYP2C9—cardiovascular system—Parkinson's disease	0.000318	0.00359	CbGeAlD
Nortriptyline—SLC6A4—nervous system—Parkinson's disease	0.000318	0.00359	CbGeAlD
Nortriptyline—CHRM1—nervous system—Parkinson's disease	0.000317	0.00358	CbGeAlD
Nortriptyline—DRD2—midbrain—Parkinson's disease	0.00031	0.0035	CbGeAlD
Nortriptyline—HTR2A—forebrain—Parkinson's disease	0.00031	0.0035	CbGeAlD
Nortriptyline—Epinastine—HTR7—Parkinson's disease	0.000309	0.0403	CrCbGaD
Nortriptyline—SLC6A4—central nervous system—Parkinson's disease	0.000306	0.00346	CbGeAlD
Nortriptyline—CHRM1—central nervous system—Parkinson's disease	0.000305	0.00344	CbGeAlD
Nortriptyline—CYP2E1—cardiovascular system—Parkinson's disease	0.000302	0.0034	CbGeAlD
Nortriptyline—CHRM3—head—Parkinson's disease	0.000299	0.00338	CbGeAlD
Nortriptyline—HTR1A—head—Parkinson's disease	0.000298	0.00336	CbGeAlD
Nortriptyline—SLC6A2—head—Parkinson's disease	0.000295	0.00333	CbGeAlD
Nortriptyline—CYP2D6—brainstem—Parkinson's disease	0.000293	0.0033	CbGeAlD
Nortriptyline—PTGS1—cardiovascular system—Parkinson's disease	0.000291	0.00328	CbGeAlD
Nortriptyline—CHRM3—nervous system—Parkinson's disease	0.000284	0.0032	CbGeAlD
Nortriptyline—CYP2D6—forebrain—Parkinson's disease	0.000282	0.00319	CbGeAlD
Nortriptyline—HTR1A—nervous system—Parkinson's disease	0.000282	0.00319	CbGeAlD
Nortriptyline—SLC6A2—nervous system—Parkinson's disease	0.00028	0.00316	CbGeAlD
Nortriptyline—ADRA1A—head—Parkinson's disease	0.000275	0.0031	CbGeAlD
Nortriptyline—CHRM3—central nervous system—Parkinson's disease	0.000273	0.00308	CbGeAlD
Nortriptyline—HTR1A—central nervous system—Parkinson's disease	0.000272	0.00307	CbGeAlD
Nortriptyline—SLC6A2—central nervous system—Parkinson's disease	0.00027	0.00304	CbGeAlD
Nortriptyline—DRD2—head—Parkinson's disease	0.000269	0.00304	CbGeAlD
Nortriptyline—Maprotiline—HTR7—Parkinson's disease	0.000266	0.0347	CrCbGaD
Nortriptyline—CHRM2—brain—Parkinson's disease	0.000266	0.003	CbGeAlD
Nortriptyline—HTR1A—cerebellum—Parkinson's disease	0.000266	0.003	CbGeAlD
Nortriptyline—HTR2A—cardiovascular system—Parkinson's disease	0.000262	0.00296	CbGeAlD
Nortriptyline—ADRA1A—nervous system—Parkinson's disease	0.00026	0.00294	CbGeAlD
Nortriptyline—CYP2E1—medulla oblongata—Parkinson's disease	0.000258	0.00291	CbGeAlD
Nortriptyline—HTR2C—brain—Parkinson's disease	0.000257	0.00289	CbGeAlD
Nortriptyline—DRD2—nervous system—Parkinson's disease	0.000255	0.00288	CbGeAlD
Nortriptyline—ADRA1A—central nervous system—Parkinson's disease	0.000251	0.00283	CbGeAlD
Nortriptyline—ALB—brain—Parkinson's disease	0.00025	0.00282	CbGeAlD
Nortriptyline—DRD2—central nervous system—Parkinson's disease	0.000246	0.00277	CbGeAlD
Nortriptyline—ADRA1A—cerebellum—Parkinson's disease	0.000245	0.00277	CbGeAlD
Nortriptyline—SLC6A4—brain—Parkinson's disease	0.000243	0.00274	CbGeAlD
Nortriptyline—CHRM1—brain—Parkinson's disease	0.000242	0.00273	CbGeAlD
Nortriptyline—DRD2—cerebellum—Parkinson's disease	0.00024	0.00271	CbGeAlD
Nortriptyline—Maprotiline—SLC6A3—Parkinson's disease	0.000233	0.0303	CrCbGaD
Nortriptyline—CYP2E1—spinal cord—Parkinson's disease	0.00023	0.00259	CbGeAlD
Nortriptyline—HTR2A—medulla oblongata—Parkinson's disease	0.000224	0.00253	CbGeAlD
Nortriptyline—PTGS1—spinal cord—Parkinson's disease	0.000221	0.0025	CbGeAlD
Nortriptyline—CHRM3—brain—Parkinson's disease	0.000217	0.00245	CbGeAlD
Nortriptyline—HTR1A—brain—Parkinson's disease	0.000216	0.00244	CbGeAlD
Nortriptyline—SLC6A2—brain—Parkinson's disease	0.000214	0.00242	CbGeAlD
Nortriptyline—HRH1—head—Parkinson's disease	0.000213	0.0024	CbGeAlD
Nortriptyline—HTR2A—midbrain—Parkinson's disease	0.000205	0.00231	CbGeAlD
Nortriptyline—CYP2E1—head—Parkinson's disease	0.000204	0.00231	CbGeAlD
Nortriptyline—HRH1—nervous system—Parkinson's disease	0.000202	0.00227	CbGeAlD
Nortriptyline—Clomipramine—GSTP1—Parkinson's disease	0.0002	0.026	CrCbGaD
Nortriptyline—HTR2A—spinal cord—Parkinson's disease	0.0002	0.00225	CbGeAlD
Nortriptyline—ADRA1A—brain—Parkinson's disease	0.000199	0.00225	CbGeAlD
Nortriptyline—PTGS1—head—Parkinson's disease	0.000197	0.00222	CbGeAlD
Nortriptyline—DRD2—brain—Parkinson's disease	0.000195	0.0022	CbGeAlD
Nortriptyline—HRH1—central nervous system—Parkinson's disease	0.000194	0.00219	CbGeAlD
Nortriptyline—CYP2E1—nervous system—Parkinson's disease	0.000194	0.00219	CbGeAlD
Nortriptyline—Protriptyline—CYP2D6—Parkinson's disease	0.000192	0.025	CrCbGaD
Nortriptyline—PTGS1—nervous system—Parkinson's disease	0.000187	0.00211	CbGeAlD
Nortriptyline—CYP2E1—central nervous system—Parkinson's disease	0.000186	0.0021	CbGeAlD
Nortriptyline—CYP2E1—cerebellum—Parkinson's disease	0.000182	0.00206	CbGeAlD
Nortriptyline—Cyproheptadine—HTR1A—Parkinson's disease	0.000181	0.0236	CrCbGaD
Nortriptyline—PTGS1—central nervous system—Parkinson's disease	0.00018	0.00203	CbGeAlD
Nortriptyline—Mianserin—HTR7—Parkinson's disease	0.000179	0.0233	CrCbGaD
Nortriptyline—HTR2A—head—Parkinson's disease	0.000178	0.002	CbGeAlD
Nortriptyline—Maprotiline—DRD2—Parkinson's disease	0.000173	0.0226	CrCbGaD
Nortriptyline—HTR2A—nervous system—Parkinson's disease	0.000168	0.0019	CbGeAlD
Nortriptyline—Mianserin—DRD3—Parkinson's disease	0.000168	0.0219	CrCbGaD
Nortriptyline—HTR2A—central nervous system—Parkinson's disease	0.000162	0.00183	CbGeAlD
Nortriptyline—CYP2D6—head—Parkinson's disease	0.000162	0.00183	CbGeAlD
Nortriptyline—Atomoxetine—SLC6A3—Parkinson's disease	0.00016	0.0209	CrCbGaD
Nortriptyline—HTR2A—cerebellum—Parkinson's disease	0.000158	0.00179	CbGeAlD
Nortriptyline—Cyclobenzaprine—HTR2A—Parkinson's disease	0.000157	0.0204	CrCbGaD
Nortriptyline—Mianserin—SLC6A3—Parkinson's disease	0.000157	0.0204	CrCbGaD
Nortriptyline—CYP3A4—nervous system—Parkinson's disease	0.000156	0.00176	CbGeAlD
Nortriptyline—Epinastine—HTR2A—Parkinson's disease	0.000155	0.0202	CrCbGaD
Nortriptyline—HRH1—brain—Parkinson's disease	0.000154	0.00174	CbGeAlD
Nortriptyline—Cyproheptadine—DRD2—Parkinson's disease	0.000154	0.02	CrCbGaD
Nortriptyline—CYP2D6—nervous system—Parkinson's disease	0.000153	0.00173	CbGeAlD
Nortriptyline—Chlorprothixene—DRD3—Parkinson's disease	0.000153	0.0199	CrCbGaD
Nortriptyline—Chlorprothixene—DRD1—Parkinson's disease	0.00015	0.0196	CrCbGaD
Nortriptyline—CYP3A4—central nervous system—Parkinson's disease	0.00015	0.00169	CbGeAlD
Nortriptyline—CYP2E1—brain—Parkinson's disease	0.000148	0.00167	CbGeAlD
Nortriptyline—CYP2D6—central nervous system—Parkinson's disease	0.000148	0.00167	CbGeAlD
Nortriptyline—CYP2D6—cerebellum—Parkinson's disease	0.000144	0.00163	CbGeAlD
Nortriptyline—Cyclobenzaprine—CYP2D6—Parkinson's disease	0.000143	0.0187	CrCbGaD
Nortriptyline—PTGS1—brain—Parkinson's disease	0.000143	0.00161	CbGeAlD
Nortriptyline—Epinastine—CYP2D6—Parkinson's disease	0.000142	0.0185	CrCbGaD
Nortriptyline—Mianserin—HTR1A—Parkinson's disease	0.000137	0.0179	CrCbGaD
Nortriptyline—Protriptyline—ABCB1—Parkinson's disease	0.000137	0.0178	CrCbGaD
Nortriptyline—Maprotiline—HTR2A—Parkinson's disease	0.000134	0.0174	CrCbGaD
Nortriptyline—Trimipramine—SLC6A3—Parkinson's disease	0.000132	0.0172	CrCbGaD
Nortriptyline—HTR2A—brain—Parkinson's disease	0.000129	0.00145	CbGeAlD
Nortriptyline—Maprotiline—CYP2D6—Parkinson's disease	0.000122	0.0159	CrCbGaD
Nortriptyline—Cyproheptadine—HTR2A—Parkinson's disease	0.000119	0.0155	CrCbGaD
Nortriptyline—CYP2D6—brain—Parkinson's disease	0.000117	0.00132	CbGeAlD
Nortriptyline—Mianserin—DRD2—Parkinson's disease	0.000116	0.0152	CrCbGaD
Nortriptyline—Trimipramine—HTR1A—Parkinson's disease	0.000115	0.015	CrCbGaD
Nortriptyline—Desipramine—SLC6A3—Parkinson's disease	0.000115	0.015	CrCbGaD
Nortriptyline—Imipramine—HTR7—Parkinson's disease	0.000112	0.0145	CrCbGaD
Nortriptyline—Amitriptyline—HTR7—Parkinson's disease	0.000111	0.0145	CrCbGaD
Nortriptyline—Doxepin—HTR1A—Parkinson's disease	0.00011	0.0143	CrCbGaD
Nortriptyline—Chlorprothixene—DRD2—Parkinson's disease	0.000106	0.0138	CrCbGaD
Nortriptyline—Amitriptyline—DRD3—Parkinson's disease	0.000104	0.0136	CrCbGaD
Nortriptyline—Epinastine—ABCB1—Parkinson's disease	0.000102	0.0132	CrCbGaD
Nortriptyline—Desipramine—HTR1A—Parkinson's disease	0.000101	0.0131	CrCbGaD
Nortriptyline—Trimipramine—DRD2—Parkinson's disease	9.8e-05	0.0128	CrCbGaD
Nortriptyline—Imipramine—SLC6A3—Parkinson's disease	9.77e-05	0.0127	CrCbGaD
Nortriptyline—Doxepin—DRD2—Parkinson's disease	9.34e-05	0.0122	CrCbGaD
Nortriptyline—Atomoxetine—HTR2A—Parkinson's disease	9.2e-05	0.012	CrCbGaD
Nortriptyline—Mianserin—HTR2A—Parkinson's disease	9e-05	0.0117	CrCbGaD
Nortriptyline—Maprotiline—ABCB1—Parkinson's disease	8.74e-05	0.0114	CrCbGaD
Nortriptyline—Desipramine—DRD2—Parkinson's disease	8.57e-05	0.0112	CrCbGaD
Nortriptyline—Imipramine—HTR1A—Parkinson's disease	8.56e-05	0.0111	CrCbGaD
Nortriptyline—Amitriptyline—HTR1A—Parkinson's disease	8.51e-05	0.0111	CrCbGaD
Nortriptyline—Atomoxetine—CYP2D6—Parkinson's disease	8.42e-05	0.011	CrCbGaD
Nortriptyline—Desipramine—CYP2E1—Parkinson's disease	8.24e-05	0.0107	CrCbGaD
Nortriptyline—Clomipramine—HTR2A—Parkinson's disease	8.23e-05	0.0107	CrCbGaD
Nortriptyline—Mianserin—CYP2D6—Parkinson's disease	8.23e-05	0.0107	CrCbGaD
Nortriptyline—Chlorprothixene—HTR2A—Parkinson's disease	8.19e-05	0.0107	CrCbGaD
Nortriptyline—Trimipramine—HTR2A—Parkinson's disease	7.57e-05	0.00986	CrCbGaD
Nortriptyline—Clomipramine—CYP2D6—Parkinson's disease	7.52e-05	0.0098	CrCbGaD
Nortriptyline—Imipramine—DRD2—Parkinson's disease	7.27e-05	0.00946	CrCbGaD
Nortriptyline—Amitriptyline—DRD2—Parkinson's disease	7.22e-05	0.0094	CrCbGaD
Nortriptyline—Doxepin—HTR2A—Parkinson's disease	7.21e-05	0.00939	CrCbGaD
Nortriptyline—Imipramine—CYP2E1—Parkinson's disease	6.99e-05	0.00911	CrCbGaD
Nortriptyline—Amitriptyline—CYP2E1—Parkinson's disease	6.95e-05	0.00905	CrCbGaD
Nortriptyline—Trimipramine—CYP2D6—Parkinson's disease	6.92e-05	0.00901	CrCbGaD
Nortriptyline—Desipramine—HTR2A—Parkinson's disease	6.62e-05	0.00862	CrCbGaD
Nortriptyline—Doxepin—CYP2D6—Parkinson's disease	6.6e-05	0.00859	CrCbGaD
Nortriptyline—Desipramine—CYP2D6—Parkinson's disease	6.05e-05	0.00788	CrCbGaD
Nortriptyline—Imipramine—HTR2A—Parkinson's disease	5.61e-05	0.00731	CrCbGaD
Nortriptyline—Amitriptyline—HTR2A—Parkinson's disease	5.58e-05	0.00727	CrCbGaD
Nortriptyline—Clomipramine—ABCB1—Parkinson's disease	5.37e-05	0.007	CrCbGaD
Nortriptyline—Chlorprothixene—ABCB1—Parkinson's disease	5.35e-05	0.00697	CrCbGaD
Nortriptyline—Imipramine—CYP2D6—Parkinson's disease	5.13e-05	0.00669	CrCbGaD
Nortriptyline—Amitriptyline—CYP2D6—Parkinson's disease	5.1e-05	0.00664	CrCbGaD
Nortriptyline—Trimipramine—ABCB1—Parkinson's disease	4.94e-05	0.00644	CrCbGaD
Nortriptyline—Doxepin—ABCB1—Parkinson's disease	4.71e-05	0.00613	CrCbGaD
Nortriptyline—Desipramine—ABCB1—Parkinson's disease	4.32e-05	0.00563	CrCbGaD
Nortriptyline—Imipramine—ABCB1—Parkinson's disease	3.67e-05	0.00477	CrCbGaD
Nortriptyline—Amitriptyline—ABCB1—Parkinson's disease	3.64e-05	0.00474	CrCbGaD
Nortriptyline—CYP1A2—Metabolism—MAOB—Parkinson's disease	7.03e-06	4.58e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—EDN1—Parkinson's disease	7.03e-06	4.58e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—APOE—Parkinson's disease	7.01e-06	4.57e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—GPX1—Parkinson's disease	6.85e-06	4.46e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—CYP2E1—Parkinson's disease	6.84e-06	4.45e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—IGF1R—Parkinson's disease	6.81e-06	4.43e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—NQO1—Parkinson's disease	6.76e-06	4.4e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—EDN1—Parkinson's disease	6.73e-06	4.38e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	6.71e-06	4.37e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	6.69e-06	4.36e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—TH—Parkinson's disease	6.66e-06	4.34e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—APOE—Parkinson's disease	6.64e-06	4.32e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—INS—Parkinson's disease	6.63e-06	4.32e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—APOE—Parkinson's disease	6.59e-06	4.29e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—COMT—Parkinson's disease	6.59e-06	4.29e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—CTGF—Parkinson's disease	6.59e-06	4.29e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—COMT—Parkinson's disease	6.58e-06	4.28e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—GSTP1—Parkinson's disease	6.56e-06	4.27e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—GSTP1—Parkinson's disease	6.55e-06	4.26e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—MAOA—Parkinson's disease	6.54e-06	4.26e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—MAOA—Parkinson's disease	6.53e-06	4.25e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IGF2—Parkinson's disease	6.49e-06	4.23e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—NGF—Parkinson's disease	6.49e-06	4.23e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—HMOX1—Parkinson's disease	6.47e-06	4.21e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—NGF—Parkinson's disease	6.46e-06	4.21e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—HMOX1—Parkinson's disease	6.46e-06	4.2e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—DDC—Parkinson's disease	6.45e-06	4.2e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—CYCS—Parkinson's disease	6.4e-06	4.16e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IGF2—Parkinson's disease	6.39e-06	4.16e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IGF2—Parkinson's disease	6.37e-06	4.15e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IGF2—Parkinson's disease	6.35e-06	4.14e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IGF2—Parkinson's disease	6.33e-06	4.12e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—MTHFR—Parkinson's disease	6.32e-06	4.12e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IGF1R—Parkinson's disease	6.28e-06	4.09e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IGF2—Parkinson's disease	6.27e-06	4.08e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IGF2—Parkinson's disease	6.26e-06	4.07e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—INS—Parkinson's disease	6.26e-06	4.07e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—ABCB1—Parkinson's disease	6.21e-06	4.04e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—EDN1—Parkinson's disease	6.2e-06	4.04e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—ABCB1—Parkinson's disease	6.2e-06	4.03e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—NGF—Parkinson's disease	6.18e-06	4.03e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—HTR2A—Parkinson's disease	6.18e-06	4.02e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IGF1R—Parkinson's disease	6.18e-06	4.02e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IGF1R—Parkinson's disease	6.16e-06	4.01e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—HTR2A—Parkinson's disease	6.15e-06	4e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IGF1R—Parkinson's disease	6.14e-06	4e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	6.14e-06	4e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IGF1R—Parkinson's disease	6.12e-06	3.99e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	6.12e-06	3.98e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—EDN1—Parkinson's disease	6.1e-06	3.97e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GSTA4—Parkinson's disease	6.09e-06	3.97e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—EDN1—Parkinson's disease	6.09e-06	3.97e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—EDN1—Parkinson's disease	6.07e-06	3.95e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—NQO1—Parkinson's disease	6.07e-06	3.95e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IGF1R—Parkinson's disease	6.06e-06	3.95e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—CTGF—Parkinson's disease	6.06e-06	3.94e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—EDN1—Parkinson's disease	6.05e-06	3.94e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IGF1R—Parkinson's disease	6.05e-06	3.94e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—GSTM1—Parkinson's disease	6.03e-06	3.92e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—GSTM1—Parkinson's disease	6.02e-06	3.92e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—CTGF—Parkinson's disease	6e-06	3.91e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—EDN1—Parkinson's disease	5.99e-06	3.9e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—INS—Parkinson's disease	5.99e-06	3.9e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—TH—Parkinson's disease	5.98e-06	3.89e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—EDN1—Parkinson's disease	5.98e-06	3.89e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—HTR2A—Parkinson's disease	5.89e-06	3.83e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—APOE—Parkinson's disease	5.89e-06	3.83e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—GPX1—Parkinson's disease	5.77e-06	3.76e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—GPX1—Parkinson's disease	5.76e-06	3.75e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—APOE—Parkinson's disease	5.75e-06	3.74e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—CYCS—Parkinson's disease	5.74e-06	3.74e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—APOE—Parkinson's disease	5.72e-06	3.72e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—NGF—Parkinson's disease	5.7e-06	3.71e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—INS—Parkinson's disease	5.67e-06	3.69e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—COMT—Parkinson's disease	5.66e-06	3.69e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	5.64e-06	3.67e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—GSTP1—Parkinson's disease	5.64e-06	3.67e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—INS—Parkinson's disease	5.63e-06	3.67e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—MAOA—Parkinson's disease	5.62e-06	3.66e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—NGF—Parkinson's disease	5.61e-06	3.65e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—NGF—Parkinson's disease	5.6e-06	3.64e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	5.6e-06	3.64e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—NQO1—Parkinson's disease	5.58e-06	3.63e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—NGF—Parkinson's disease	5.58e-06	3.63e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—NGF—Parkinson's disease	5.56e-06	3.62e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—HMOX1—Parkinson's disease	5.56e-06	3.62e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—NQO1—Parkinson's disease	5.53e-06	3.6e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—NGF—Parkinson's disease	5.51e-06	3.59e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—TH—Parkinson's disease	5.5e-06	3.58e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—NGF—Parkinson's disease	5.49e-06	3.58e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	5.48e-06	3.57e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—APOE—Parkinson's disease	5.47e-06	3.56e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—TH—Parkinson's disease	5.45e-06	3.55e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—MAOB—Parkinson's disease	5.43e-06	3.53e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—HTR2A—Parkinson's disease	5.43e-06	3.53e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—ABCB1—Parkinson's disease	5.34e-06	3.47e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—HTR2A—Parkinson's disease	5.33e-06	3.47e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—MTHFR—Parkinson's disease	5.33e-06	3.47e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—MTHFR—Parkinson's disease	5.32e-06	3.46e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—HTR2A—Parkinson's disease	5.31e-06	3.46e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—HTR2A—Parkinson's disease	5.29e-06	3.45e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—CYCS—Parkinson's disease	5.28e-06	3.44e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—HTR2A—Parkinson's disease	5.24e-06	3.41e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—CYCS—Parkinson's disease	5.24e-06	3.41e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—HTR2A—Parkinson's disease	5.23e-06	3.4e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	5.23e-06	3.4e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—GSTM1—Parkinson's disease	5.18e-06	3.37e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CTGF—Parkinson's disease	5.13e-06	3.34e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—COMT—Parkinson's disease	5.08e-06	3.31e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—GSTP1—Parkinson's disease	5.06e-06	3.3e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—MAOA—Parkinson's disease	5.05e-06	3.29e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—APOE—Parkinson's disease	5.04e-06	3.28e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—INS—Parkinson's disease	5.03e-06	3.27e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—HMOX1—Parkinson's disease	4.99e-06	3.25e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—APOE—Parkinson's disease	4.96e-06	3.23e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—GPX1—Parkinson's disease	4.96e-06	3.23e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—APOE—Parkinson's disease	4.96e-06	3.23e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—APOE—Parkinson's disease	4.95e-06	3.23e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—APOE—Parkinson's disease	4.95e-06	3.22e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—APOE—Parkinson's disease	4.94e-06	3.21e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—CASP3—Parkinson's disease	4.94e-06	3.21e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—APOE—Parkinson's disease	4.92e-06	3.2e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—INS—Parkinson's disease	4.91e-06	3.2e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling by GPCR—IL6—Parkinson's disease	4.91e-06	3.19e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—INS—Parkinson's disease	4.88e-06	3.18e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—APOE—Parkinson's disease	4.87e-06	3.17e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—APOE—Parkinson's disease	4.86e-06	3.16e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—ABCB1—Parkinson's disease	4.79e-06	3.12e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	4.78e-06	3.11e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—NQO1—Parkinson's disease	4.73e-06	3.08e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—COMT—Parkinson's disease	4.68e-06	3.05e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—INS—Parkinson's disease	4.67e-06	3.04e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—TH—Parkinson's disease	4.66e-06	3.03e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—CASP3—Parkinson's disease	4.66e-06	3.03e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—GSTP1—Parkinson's disease	4.65e-06	3.03e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—GSTM1—Parkinson's disease	4.65e-06	3.03e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—MAOA—Parkinson's disease	4.64e-06	3.02e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—COMT—Parkinson's disease	4.64e-06	3.02e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling by GPCR—IL6—Parkinson's disease	4.63e-06	3.01e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—GSTP1—Parkinson's disease	4.61e-06	3e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—MAOA—Parkinson's disease	4.6e-06	3e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—HMOX1—Parkinson's disease	4.59e-06	2.99e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—MTHFR—Parkinson's disease	4.58e-06	2.98e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—HMOX1—Parkinson's disease	4.55e-06	2.96e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—MAPK8—Parkinson's disease	4.54e-06	2.95e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CYCS—Parkinson's disease	4.47e-06	2.91e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—CASP3—Parkinson's disease	4.46e-06	2.9e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—GPX1—Parkinson's disease	4.45e-06	2.9e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—IL6—Parkinson's disease	4.43e-06	2.89e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—ABCB1—Parkinson's disease	4.41e-06	2.87e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—ABCB1—Parkinson's disease	4.37e-06	2.84e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—INS—Parkinson's disease	4.31e-06	2.81e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—MAPK8—Parkinson's disease	4.28e-06	2.79e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—GSTM1—Parkinson's disease	4.28e-06	2.79e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—APOE—Parkinson's disease	4.26e-06	2.78e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—INS—Parkinson's disease	4.24e-06	2.76e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—GSTM1—Parkinson's disease	4.24e-06	2.76e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—INS—Parkinson's disease	4.24e-06	2.76e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—INS—Parkinson's disease	4.23e-06	2.76e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—INS—Parkinson's disease	4.23e-06	2.75e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—INS—Parkinson's disease	4.22e-06	2.75e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—INS—Parkinson's disease	4.2e-06	2.74e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—CASP3—Parkinson's disease	4.19e-06	2.73e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—IL6—Parkinson's disease	4.17e-06	2.71e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—INS—Parkinson's disease	4.16e-06	2.71e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—INS—Parkinson's disease	4.15e-06	2.7e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—MTHFR—Parkinson's disease	4.11e-06	2.68e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—MAPK8—Parkinson's disease	4.1e-06	2.67e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—GPX1—Parkinson's disease	4.1e-06	2.67e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—GPX1—Parkinson's disease	4.06e-06	2.64e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	4.03e-06	2.63e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—COMT—Parkinson's disease	3.96e-06	2.58e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CTGF—Parkinson's disease	3.96e-06	2.58e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—GSTP1—Parkinson's disease	3.94e-06	2.57e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—MAOA—Parkinson's disease	3.93e-06	2.56e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—HMOX1—Parkinson's disease	3.89e-06	2.53e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—MAPK8—Parkinson's disease	3.85e-06	2.51e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—APOE—Parkinson's disease	3.83e-06	2.49e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—MTHFR—Parkinson's disease	3.78e-06	2.46e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—MTHFR—Parkinson's disease	3.75e-06	2.44e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—ABCB1—Parkinson's disease	3.73e-06	2.43e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	3.69e-06	2.4e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—CASP3—Parkinson's disease	3.65e-06	2.38e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—NQO1—Parkinson's disease	3.65e-06	2.38e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—INS—Parkinson's disease	3.64e-06	2.37e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—CASP3—Parkinson's disease	3.64e-06	2.37e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—IL6—Parkinson's disease	3.63e-06	2.36e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—GSTM1—Parkinson's disease	3.62e-06	2.36e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—IL6—Parkinson's disease	3.61e-06	2.35e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—TH—Parkinson's disease	3.6e-06	2.34e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—APOE—Parkinson's disease	3.52e-06	2.29e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—APOE—Parkinson's disease	3.49e-06	2.27e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CASP3—Parkinson's disease	3.48e-06	2.27e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—GPX1—Parkinson's disease	3.47e-06	2.26e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—IL6—Parkinson's disease	3.46e-06	2.25e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CYCS—Parkinson's disease	3.45e-06	2.25e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—MAPK8—Parkinson's disease	3.36e-06	2.19e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—MAPK8—Parkinson's disease	3.34e-06	2.18e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—INS—Parkinson's disease	3.27e-06	2.13e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CASP3—Parkinson's disease	3.21e-06	2.09e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—MTHFR—Parkinson's disease	3.2e-06	2.09e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—MAPK8—Parkinson's disease	3.2e-06	2.08e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—IL6—Parkinson's disease	3.19e-06	2.08e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CASP3—Parkinson's disease	3.16e-06	2.06e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CASP3—Parkinson's disease	3.15e-06	2.05e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CASP3—Parkinson's disease	3.14e-06	2.04e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—IL6—Parkinson's disease	3.14e-06	2.04e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CASP3—Parkinson's disease	3.13e-06	2.04e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—IL6—Parkinson's disease	3.13e-06	2.04e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—IL6—Parkinson's disease	3.12e-06	2.03e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—IL6—Parkinson's disease	3.11e-06	2.03e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CASP3—Parkinson's disease	3.1e-06	2.02e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CASP3—Parkinson's disease	3.09e-06	2.01e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—IL6—Parkinson's disease	3.08e-06	2.01e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—IL6—Parkinson's disease	3.07e-06	2e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—COMT—Parkinson's disease	3.06e-06	1.99e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GSTP1—Parkinson's disease	3.04e-06	1.98e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—MAOA—Parkinson's disease	3.04e-06	1.98e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—INS—Parkinson's disease	3.01e-06	1.96e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—HMOX1—Parkinson's disease	3e-06	1.95e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—APOE—Parkinson's disease	2.98e-06	1.94e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—INS—Parkinson's disease	2.98e-06	1.94e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—MAPK8—Parkinson's disease	2.95e-06	1.92e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—MAPK8—Parkinson's disease	2.9e-06	1.89e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—IL6—Parkinson's disease	2.9e-06	1.89e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—MAPK8—Parkinson's disease	2.9e-06	1.89e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—MAPK8—Parkinson's disease	2.89e-06	1.88e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—ABCB1—Parkinson's disease	2.88e-06	1.88e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—MAPK8—Parkinson's disease	2.88e-06	1.87e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—MAPK8—Parkinson's disease	2.85e-06	1.86e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—MAPK8—Parkinson's disease	2.84e-06	1.85e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GSTM1—Parkinson's disease	2.8e-06	1.82e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—IL6—Parkinson's disease	2.73e-06	1.78e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GPX1—Parkinson's disease	2.68e-06	1.74e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—IL6—Parkinson's disease	2.62e-06	1.7e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—INS—Parkinson's disease	2.55e-06	1.66e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—MTHFR—Parkinson's disease	2.47e-06	1.61e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—IL6—Parkinson's disease	2.46e-06	1.6e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—APOE—Parkinson's disease	2.3e-06	1.5e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—IL6—Parkinson's disease	2.14e-06	1.4e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—IL6—Parkinson's disease	2.13e-06	1.39e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—IL6—Parkinson's disease	2.04e-06	1.33e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—INS—Parkinson's disease	1.97e-06	1.28e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IL6—Parkinson's disease	1.88e-06	1.23e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IL6—Parkinson's disease	1.85e-06	1.21e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IL6—Parkinson's disease	1.85e-06	1.2e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IL6—Parkinson's disease	1.84e-06	1.2e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IL6—Parkinson's disease	1.84e-06	1.2e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IL6—Parkinson's disease	1.82e-06	1.18e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IL6—Parkinson's disease	1.81e-06	1.18e-05	CbGpPWpGaD
